2025 Canine Arthritis Treatment Market Outlook: Key Indicators Shaping Growth Through 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Canine Arthritis Treatment Industry Market Size Be by 2025?
The market for treating canine arthritis has seen robust growth in the past years. The market, valued at $2.35 billion in 2024, is projected to reach $2.47 billion in 2025, experiencing a Compound Annual Growth Rate (CAGR) of 5.3%. Factors fueling this expansion over the past include an increasing population of older pets, heightened awareness among pet owners, an emphasis on preventative care, a rise in disposable income, and more spending on veterinary care.

What's the Long-Term Growth Forecast for the Canine Arthritis Treatment Market Size Through 2029?
In the upcoming years, the canine arthritis treatment market is projected to experience robust growth. The market value is predicted to reach $3.01 billion by 2029, expanding at a compound annual growth rate (CAGR) of 5.0%. Factors contributing to this anticipated growth during the forecast period include increased pet insurance uptake, higher incidence of arthritis, more people owning pets, a growing preference for minimally invasive surgery, and a rise in cases of arthritis in dogs. The forecast period is also expected to see key trends such as cutting-edge treatments, progress in veterinary medicine, demand for advanced therapies, technology integration, and the development of innovative technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/canine-arthritis-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Canine Arthritis Treatment Market Expansion?
The canine arthritis treatment market's growth is anticipated to be fuelled by the increasing trend of owning pets. Having a pet usually refers to the responsibilities and care that individuals or households provide for their domesticated animals, which are primarily kept for pleasure, not utility. Lifestyle changes, inflating disposable incomes, and pet humanization are among the factors contributing to an increase in pet ownership. To manage and ease the symptoms of arthritis in their dogs and improve their living quality and mobility, pet owners are turning to canine arthritis treatments. The American Pet Products Association, a non-profit organization based in the US, reported in October 2023 that 86.9 million US households had a pet, making up 66% of households in 2022. Hence, the growth of the canine arthritis treatment market is being propelled by the increasing pet ownership rate.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16007&type=smp

What Are the Key Trends Driving Canine Arthritis Treatment Market Growth?
Leading businesses in the canine arthritis treatment market are introducing progressive therapies, such as bedinvetmab injections, to tackle issues related to joint health and mobility in dogs. Bedinvetmab is an injected monoclonal antibody that operates by identifying and nullifying nerve growth factor (NGF), an important protein associated with pain in veterinary medicine. As an example, in May 2023, Zoetis Inc., a major animal health firm in the United States, earned approval from the FDA for Librela, an injection of bedinvetmab. This marks the first endorsement of a monoclonal antibody (mAb) by the FDA for usage in dogs. The drug works by latching onto and curbing the biological performance of canine NGF, which plays a key role in managing pain linked to OA. This treatment is delivered through a subcutaneous injection once monthly, making it a suitable and long-lasting solution for managing pain caused by canine OA.

How Is the Canine Arthritis Treatment Market Segmented?
The canine arthritis treatment market covered in this report is segmented -

1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16007&type=smp

Which Companies Are Leading the Charge in Canine Arthritis Treatment Market Innovation?
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill's Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.

Which Regions Are Leading the Global Canine Arthritis Treatment Market in Revenue?
North America was the largest region in the canine arthritis treatment market in 2024. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16007

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.